Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase

J Clin Oncol. 2011 Jun 10;29(17):e514-6. doi: 10.1200/JCO.2010.34.1610. Epub 2011 Apr 4.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Blast Crisis / diagnosis
  • Blast Crisis / pathology*
  • Bone Marrow / pathology
  • Dasatinib
  • Femur / pathology
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Male
  • Mastocytosis, Systemic / drug therapy
  • Mastocytosis, Systemic / pathology*
  • Middle Aged
  • Orbital Neoplasms / pathology
  • Protein Kinase Inhibitors / therapeutic use*
  • Proto-Oncogene Proteins c-kit / analysis
  • Pyrimidines / therapeutic use*
  • Thiazoles / therapeutic use*

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Proto-Oncogene Proteins c-kit
  • Dasatinib